-+ 0.00%
-+ 0.00%
-+ 0.00%

Lupin Limited Just Recorded A 12% EPS Beat: Here's What Analysts Are Forecasting Next

Simply Wall St·08/08/2025 00:45:59
Listen to the news
NSEI:LUPIN 1 Year Share Price vs Fair Value
NSEI:LUPIN 1 Year Share Price vs Fair Value
Explore Lupin's Fair Values from the Community and select yours

Lupin Limited (NSE:LUPIN) last week reported its latest first-quarter results, which makes it a good time for investors to dive in and see if the business is performing in line with expectations. Revenues were ₹63b, approximately in line with expectations, although statutory earnings per share (EPS) performed substantially better. EPS of ₹26.62 were also better than expected, beating analyst predictions by 12%. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

earnings-and-revenue-growth
NSEI:LUPIN Earnings and Revenue Growth August 8th 2025

Following the latest results, Lupin's 36 analysts are now forecasting revenues of ₹254.0b in 2026. This would be a meaningful 8.7% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to rise 8.9% to ₹88.19. Before this earnings report, the analysts had been forecasting revenues of ₹254.3b and earnings per share (EPS) of ₹87.68 in 2026. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

Check out our latest analysis for Lupin

It will come as no surprise then, to learn that the consensus price target is largely unchanged at ₹2,224. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. There are some variant perceptions on Lupin, with the most bullish analyst valuing it at ₹2,623 and the most bearish at ₹1,729 per share. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. The analysts are definitely expecting Lupin's growth to accelerate, with the forecast 12% annualised growth to the end of 2026 ranking favourably alongside historical growth of 9.4% per annum over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 10% annually. Factoring in the forecast acceleration in revenue, it's pretty clear that Lupin is expected to grow at about the same rate as the wider industry.

The Bottom Line

The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. The consensus price target held steady at ₹2,224, with the latest estimates not enough to have an impact on their price targets.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Lupin analysts - going out to 2028, and you can see them free on our platform here.

Don't forget that there may still be risks. For instance, we've identified 1 warning sign for Lupin that you should be aware of.